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Abstract 
Xanthan gum, a hydrophilic biopolymer with modified release properties, was used to 
produce directly compressed matrix tablets containing a model drug, Sodium p-
aminosalicylate. Three formulations were prepared, each containing a different calcium 
dihydrate salt: Calcium Chloride, Calcium Sulfate or Dibasic Calcium Phosphate.  The aim of 
the investigation was to relate the calcium ion content and solubility of the calcium salt to 
the in vitro drug release profile of the xanthan matrices.  Tablet hydration, erosion and drug 
release were determined in distilled water using the BP paddle method. The data showed 
that the overall drug release was the greatest with addition of calcium Sulfate, followed by 
Calcium Chloride and dibasic Calcium Phosphate. The chloride salt formulation displayed the 
greatest percentage erosion due to rapid mass loss during the initial phase, followed by 
those with sulfate or phosphate salts. As xanthan gel viscosity increased and drug release 
was also found to be lower. It can be concluded that drug release is influenced by the 
solubility of the salt present in the formulation, since these parameters determine the 
viscosity and structure of the gel layer. 
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Introduction 
Matrix tablet systems are prolonged release formulations. Matrix tablets that are primarily 
diffusional dependant are composed of a water insoluble polymer, which forms a porous 
matrix containing dispersed drug particles. Comparatively, hydrophilic colloid matrix 
systems are intended to modulate drug release through diffusion and erosion mechanisms. 
This system comprises of a water swellable hydrophilic polymer that forms a hydrated 
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matrix layer on contact with water. The rate of drug release is dependent on the 
penetration of water through the hydrated matrix layer, into the non-hydrated core and the 
diffusion of dissolved drug through the matrix. The outer hydrated layer will erode as it 
becomes more dilute and a new gel layer will form as the succeeding surface becomes 
hydrated. Historically, cellulose ether derivatives such as hydroxypropylmethyl cellulose 
(HPMC) have been used in matrix formulations due to their rapid hydration when in contact 
with water
1
. However, there is increasing interest in alternative natural polymers such as 
xanthan gum (XG).   
Xanthan gum is a high molecular weight anionic polysaccharide gum, produced by pure-
culture aerobic fermentation of a carbohydrate with the gram-negative bacterium, 
Xanthomonas compestris
2
. The polymer has extensive use in the food and cosmetic 
industries as a viscosity increasing agent and within the pharmaceutical industry as a 
hydrocolloid to thicken, suspend and stabilize water based systems
3
. Moreover, XG based 
matrix tablets have been proven to sustain drug release in a predictable manner due to XG’s 
gelling properties. The primary structure of the gum contains repeated units of five sugar 
residues; two D-glucose units, two D-mannose units, and one D-glucuronic acid. The 
polymer backbone is identical to the structure of cellulose and consists of β-D-glucose units 
linked at the one and four positions. The side chain found on alternating anhydroglucose 
units is composed of: β-D-mannose-β-D-glucuronic acid-α-D-mannose. This trisaccharide 
side chain is the characteristic, which distinguishes xanthan from cellulose
2
.  Depending on 
the bacterial strain and fermentation conditions used, the terminal mannose residue may 
carry a pyruvate moiety and the non-terminal mannose unit carries an acetyl functional 
group.  The anionic character of XG is attributed to the pyruvate and glucuronic acid groups 
in the structure
3
.  
Drug release from xanthan gum matrix tablets is believed to be a complex interaction 
between; diffusion, swelling and erosion mechanisms
3-5
. When the hydrophilic polymer 
comes in contact with an aqueous medium the liquid penetrates and the matrix gradually 
hydrates and swells from the periphery to the centre of the tablet. Subsequently, the 
diameter of the tablet progressively increases and a gelatinous mass forms. This 
phenomenon occurs due to the formation of hydrogen bonds between XG and water, which 
causes the uncoiling of XG molecules. XG tablets consist of three regions: the highly swollen 
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outer gel layer, which acts as a diffusional barrier to retard drug release and further uptake 
of water; the moderately swollen, rubbery middle layer and the inner dry glassy core
4
.  The 
thickness of the outer gel layer determines the diffusional path length of a water soluble 
drug and controls its release through Fickian diffusion during the initial phase
5
. However, as 
XG is hydrophilic in nature the polymer undergoes a relaxation process after hydration. This 
results in slow direct erosion of the outer layer, which affects the dimension of the matrices 
and thus influences subsequent drug release
6
. Soluble drugs are released through a 
combination of swelling and erosion mechanisms; however, for insoluble drugs matrix 
erosion is the most predominant release factor
3
. Furthermore, as swelling and erosion occur 
simultaneously, both mechanisms will control the overall drug release rate. Hence, a precise 
balance between the two factors is required to optimise drug release
5
. Sustained release XG 
matrix tablets have been investigated in numerous studies
4, 7-9
 and provide evidences of 
XG’s ability to prolong drug release. Talukdar, et al. (1998) reported that XG matrix tablets 
containing 50mg of indomethacin had the same in vitro drug release profile and displayed 
superior therapeutic efficacy in vivo compared to the reference product Flexin®
8
. The results 
showed XG tablets could reach the minimum effective concentration earlier and remained 
in range longer than the marketed equivalent. Furthermore, a gamma-scintigraphic study of 
the gastrointestinal transit of XG matrix tablets supports the viability of XG as a controlled 
release agent
7
.  In order to improve sustained release performance of matrix system, XG has 
been used in combination with other natural excipients; chitosan, guar gum, karaya gum, 
galactomanan and sodium alginate
2
. The synergistic interactions between galactomannan 
and xanthan have been investigated in the formulation of directly compressed theophylline 
tablets
4,9
. Vendruscolo et al. (2005) found that drug release decreased with increased XG 
concentration. The authors conclude that tablets containing 8% XG and 8% galactomannan 
provide the most appropriate sustained release properties, with approximately 90% drug 
release at the end of 8 hours
9
.  The work conducted by Jian et al. (2012) supports the theory 
that binary mixtures of xanthan gum and galactomannan matrix tablets retard diffusion of 
theophylline
4
.   
Numerous variables have been investigated which can change the drug release 
characteristics of XG matrix such as pH, temperature, ionic strength of the medium and the 
presence of divalent counterions within the tablet. The work conducted by Talukdar & 
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Kinget (1995) showed that the swelling rate of XG system in an acidic medium was 
significantly lower than in neutral or alkaline solutions
3
. This phenomenon occurs because 
XG is an acidic polymer with a pKa of 3.1, thus at lower pH values the polymer is less soluble 
and swelling rate is suppressed
3
. Hence, as the swelling capacity of the polymer will be 
different in the stomach and the intestine, the drug release will be affected.  
Drug release from XG matrix tablets is also sensitive to the presence of ions in the release 
medium; this is of particular importance because the ionic strength of the GI fluid varies
3
. 
Baumgartner et al. (2008) and Jaipal et al. (2013) illustrate that as the concentration of 
calcium ions within the matrix tablet increases, drug release also increases
10-11
. The effect of 
bivalent cations on the flow behaviour of XG solutions has been investigated in several 
studies
3, 10, 12-13
. At increased ionic strength the ordered structure of XG predominates and 
this impacts the viscosity of the XG gel
12
.  Also, depending on the initial concentration of XG, 
increasing ionic strength can either increase or decrease the overall hydrogel viscosity. 
Wyatt et al. (2011) shows that the critical xanthan concentration at which the addition of 
salt neither increases nor decreases viscosity is approximately 0.2% at zero shear rate 
viscosity in 50mM of Sodium Chloride. At XG concentrations greater than 0.2% the viscosity 
increases as salt content rises
14
. Whereas, when XG concentration is below the critical 
concentration, the solution viscosity decreases with increasing salt content. Therefore, the 
critical XG concentration will vary depending on the salt concentration and type of salt 
compound.  In a similar way to the ionic strength of the medium, temperature also controls 
the equilibrium between ordered and disordered chains of XG in aqueous solution
13
. At high 
temperature a disordered structure of XG predominates, whereas, at lower temperate a 
single double helix conformation is assumed. This is of particular importance because the 
conformational state of XG impacts the rheological properties of the polymer 
13
. 
This work will incorporate different inorganic calcium salts; Calcium Chloride (CaCl2.2H2O), 
Calcium Sulfate (CaSO4.2H2O) and Dibasic Calcium Phosphate (CaHPO4.2H2O) into XG based 
matrix tablets containing a model hydrophilic drug, Sodium p-aminosalicylate. The primary 
objectives for this work are to investigate the effect of calcium salts on the erosion and 
swelling properties as well as dissolution profiles of xanthan matrix tablets. A comparison of 
the influence of calcium salts on the viscosity of XG hydrogels is also explored.  
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Materials and Methods  
Materials 
Xanthan gum was supplied by A+E Connock (Perfumery & cosmetics) LTD. (Hampshire, 
England). Sodium p-aminosalicylate as dihydrate salt was provided by Sigma-Aldrich 
chemical company, Inc, (Milwaukke, USA). Avicel PH-101 NF was supplied by FMC 
Biopolymer (Philadelphia, USA). Magnesium stearate Eur. Ph was provided by Medex UK 
(Northampton, UK). Calcium Sulfate dihydrate Ph. Eur NF was supplied by JRS 
Pharmaceuticals (Rosenberg, Germany). Calcium Chloride dihydrate was provided by Fisher 
scientific UK Ltd. (Leicestershire, UK). Dibasic Calcium Phosphate dihydrate USP/BP was 
supplied by Penwest Phamacuticals LTD. (Surrey, UK). The basic properties of the calcium 
salts are provided in Table 1.  
 
Preparation of matrix tablets  
Three xanthan gum based tablet formulations were prepared by the direct compression 
method (Table 2). To produce tablet with a semi-automatic mode, excipients such as 
magnesium stearate and microcrystalline cellulose were added. For each formulation, 100g 
were thoroughly mixed for 5 minutes at 30 rpm using a tumbler mixer (Model: Glen Creston 
LTD, Stanmore UK). Subsequently, the powder mix was manually fed and automatically 
compressed using a single punch (10 mm flat faced punch) tableting machine (Model: 
Manesty machines LTD, Liverpool England, type: F3) to attain a target tablet weight of 
390mg.  
 
Calibration plot for Sodium p-aminosalicylate 
A stock solution (1mgml
-1
) was prepared by dissolving appropriate quantity of Sodium p-
aminosalicylate then made to the required volume with distilled water. A series of 
calibration standards ranging between 0.005mgml
-1
 and 0.03mgml
-1
 then prepared and 
triplet samples of the standard solutions were analyzed using a UV spectrophotometer 
(Model: M501, Spectronic Camspec Ltd, Leeds, England) at λmax of 300nm
15
. The mean 
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absorbance value for each standard solution was then plotted against the corresponding 
concentration and the calibration equation determined.  
 
Characterization of physical tablet properties   
a. Uniformity of mass 
Randomly selected tablets (n=20) from each formulation were individually weighed on an 
electronic balance and the average mass determined.  The BP states ‘not more than 2 of the 
individual masses deviate from the average mass by more than 5% and none deviates by 
more than 10%’ 
16
. 
b. Uniformity of drug content 
Randomly selected matrix tablets (n=5) from each formulation were individually weighed 
then crushed using a pestle and mortar. The resulting powder was dissolved in appropriate 
quantity of distilled water. To ensure full dissolution of the drug in the powder mix the 
samples were sonicated for 30 minutes and the solution was diluted to a final concentration 
of 0.02mgml
-1
. The samples were measured at λmax of 300nm using a UV 
spectrophotometer (Model: M501, Spectronic Camspec Ltd, Leeds, England).  Subsequently 
the average drug content was calculated using the calibration equation for Sodium p-
aminosalycilate.  The BP states ‘The preparation complies with the test if each individual 
content is between 85 percent and 115 percent of the average content. The preparation fails 
to comply with the test if more than one individual content is outside these limits or if one 
individual content is outside the limits of 75 percent to 125 percent of the average content’ 
16
. 
c. Tablet tensile strength and porosity  
The diameter and thickness of randomly selected tablets (n=10) were measured using a 
vernier caliper and the corresponding crushing load was recorded using a tablet hardness 
tester (Model: Schleuniger & Co, Switzerland, model: 2E). Subsequently, the individual 
tablet tensile strength was calculated using the equation (1). 
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=	 									…………… (1) 
where , is tensile strength (Pa); F, is force (N); D, is diameter (m) and T, is thickness (m) 
The densities of the tablet excipients were determined in a triplicate using a helium 
multipycnometer (Model: MVP-6DC, Quantachrome instruments, Boynton Beach, USA). 
Subsequently tablet porosity can be predicted by Equation 2. 
 = 	1 −  ∗ 100 ………….. (2) 
Where e, is tablet porosity (%); Pa, is the apparent density of (gcm
-3
) and Pt, is the density of 
powder (gcm
-3
)
 
 
Swelling and erosion studies  
The swelling and erosion experiment was conducted using a fully calibrated dissolution 
apparatus (Model: DT6, Copley Scientific LTD, Nottingham, England) and the BP paddle 
method, with a paddle rotating rate of 50rpm in 1000ml of distilled water (37
o
C ± 5 
O
C). For 
the test three tablets from each formulation were weighed and placed into the dissolution 
medium. Subsequently, at specified time intervals (0.5, 2, 4 and 6 hours) the tablets were 
carefully withdrawn using a spatula and the excess medium removed using tissue paper.  
The weight of the hydrated tablet was recorded and the corresponding swelling index was 
calculated (Equation 3) 
10
. The tablets were then placed in a drying cabinet (Model: LEEC, 
Nottingham, England) at 70
o
C to remove the moisture, and to reach constant mass before 
being reweighed and the percentage erosion determined (Equation 4) 
10
.  
		% =  !! ∗ 100      …………… (3) 
Where: mt, is the mass of the hydrated tablets after the determined time of swelling (g) and 
mr, is the mass of the swollen tablet after it has been dried in the oven (g) 
"#$%$		% = & !& ∗ 100      …………… (4) 
Where: m0, is the mass of the dry tablet before swelling (g) 
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‘In vitro’ drug release profile 
The dissolution test was carried out using the same conditions as described in the swelling 
and erosion experiment. Three tablets from each formulation were individually weighed 
before placing them into the dissolution medium at 37
o
C ± 0.5
o
C. Distilled water was used as 
the dissolution medium. During the dissolution test, a sample (10ml) was periodically 
withdrawn and replaced with equal volume of distilled water. The extracted sample was 
analyzed spectrophotometrically (Model: M501, Spectronic Camspec Ltd, Leeds, England) at 
300nm, and the concentration of drug in the sample was derived from the calibration curve.  
The in vitro drug release data was reanalyzed using zero order kinetics, first order kinetics, 
Higuchi, Hixson-Crowell and Korsmeyer Peppas mathematical models. For zero order 
kinetics the cumulative fraction released is a function of time
17
. First order kinetics describes 
a system, which is dependent on the concentration of the dissolved substance
18
; for this 
model natural logarithm of unreleased fraction of drug is plotted against time. The Higuchi 
model describes a diffusional based drug release from matrix systems and relates drug 
concentration to the square root of time
18
. For systems in which the surface area and 
diameter of the particles or tablets change with time the Hixson-Crowell model can be 
utilised
18
, for this model data is plotted as cube root of unreleased fraction versus time.  The 
Korsmeyer-Peppas model describes drug release from a polymeric system where complex 
release mechanisms involved, for this model fraction release is plotted against time and to 
determine the mechanism of drug release data up to 60% of drug release was fitted to 
equation 5
17
. 
'
'(
= )*+   …….. (5) 
Where: ,-, is the amount of drug released at time *; ,., is the amount of drug released at 
infinite time; ), is the rate constant; , is the diffusion exponent used to characterise the 
transport mechanism. 
 
Xanthan hydrogel for rheological investigations 
To simulate the swollen outer layer of the XG matrix tablets, four gels (1%) were prepared. 
Three of the gels contained a calcium salt (Chloride, Sulfate or Phosphate, at a ratio of 1:5 of 
9 
 
calcium salt: XG that is equivalent to the tablet formulation, Table 2) and the fourth gel 
contained no salt. The hydrogels were prepared by adding the XG and dihydrate salt to 
distilled water and the samples were then mixed using a homogeniser (Model: Silverson, 
Machines Ltd, Waterside, Chesham, UK) for 15 minutes. The gels were stored at room 
temperature to allow for complete hydration before used. After equilibrating the samples at 
37
o
C and the flow properties of the gel preparations were measured using a digital 
viscometer and spindle number 64 (Model: LVDV-IP, Brookfield Engineering Labs, 
Massachusetts, USA). The shear rate ranged from 4.18s
-1
 to 25.08s
-1
 and the spindle speed 
ranged from 20 rpm to 120 rpm. The apparent viscosity of the sample was plotted against 
shear rate and the flow properties were then described using the power law equation 
(Equation 6). 
η = k23 + 4    ………. (6) 
where η, is the viscosity (Pa.s); k, is the consistency index (Pa.s); 23 , is the shear rate (s-1), n; 
is the flow behaviour (power law) index. 
 
Scanning electron microscope imaging 
The morphological differences between the dry matrices and the swollen then dried 
matrices (4hrs) were analyzed using a scanning electron microscope (Model: S3000N, 
Hitachi High Technologies, Wokingham Berkshire, UK). The samples were prepared by 
cutting the tablets in half, mounting them onto a metal stages and coating the samples in 
gold-palladium using a coating unit (Model: SC760, Quorum Technology, Sussex, England).  
 
Statistical analysis 
Statistical analysis was performed using SPPS software (version 20.0, SPSS Inc. Chicago, 
USA). Data was determined using one-way ANOVA followed by a post hoc test. A p-value of 
<0.05 was considered as significant.  
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Results and discussions  
The results show that all formulations comply with the BP uniformity of mass and uniformity 
of content requirements (Table 3). The tensile strength readings of the formulations are 
relatively low while the ‘zero pressure’ porosities of the three batches are similar
19
.  
 
Dynamic swelling and erosion studies  
Figure 1 shows the swelling index of F1 (677%), F2 (868%) and F3 (745%) following six hours 
in contact with distilled water. F1 (containing soluble chloride salt) shows the lowest 
swelling capacity, which is consistent with radial and axial swelling results (data not 
presented). Comparatively, F3 has a lower swelling index than F2, which can be attributed to 
the hydrophobicity of the matrix tablet. The extent of matrix erosion was deduced from 
tablet’s weight loss once it had been dried in the oven. The process of matrix erosion arises 
when the outer gel layer becomes fully hydrated and the polymer chains preserving the 
layer relax and disentangle. As a result, the surface of the matrix tablet wears away due to 
loss of structural integrity
20
. Figure 2 displays the erosion profiles of the three formulations. 
After six hours in contact with the medium, F1 showed the highest erosion index (37%) 
when compared to F2 and F3. Erosion in the first thirty minutes of the experiment was 
found to be statistically faster for F1 (p <0.05), which was then followed by a reduced 
erosion rate in the later periods. Hypothetically, the initial rapid erosion of F1 occurs 
because the chloride salt readily dissociates when the water molecules influx into the tablet, 
due to its hydrophilic nature. Consequently, the calcium ions leach into the solution and the 
tablets gel layer is easily erodible, since the calcium ions are unable to interact with the XG 
polymer chains. As time progresses the gel layer proliferates until it is fully formed and can 
encapsulate the calcium ions. Subsequently, the gel is strengthened through interactions 
with the calcium ions and thus further erosion is reduced. A delay in gel layer formation was 
also reported
21
. Comparatively, the Sulfate and Phosphate salts present in F2 and F3 
respectfully are less hydrophilic and as a result undergo less initial erosion, allowing for the 
fully hydrated gel layer to develop. The rate of erosion can be deduced from the gradient of 
the curve (Figure 2); the data indicates that F2 (3.1 hr
-1
) has a higher rate of erosion than F3 
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and F1, which have similar rates (2.9 hr
-1
). This trend can be explained by the viscosity of the 
gel layer as described later.  
 
Rheological characterisation of XG hydrogels  
The rheology of XG solutions in the presence of mono- and divalent ions is dependent on 
xanthan concentration. The effects of salt concentration on flow behaviour can be 
attributed to the molecular conformation states of XG. Xanthan gum is known to exist in 
two different conformational states: ordered and disordered. In salt free solution the 
disordered conformation predominates, in which the pyruvate unit on the side chains are 
ionised, highly solvated and repel mutual charges and thus project away from the backbone 
and the molecule occupies a larger hydrodynamic volume. Strong Coulombic repulsions 
between like charges along the polyelectrolyte backbone also stretch and elongate the 
individual chains
22
. It is believed that the pyruvate unit forms the principle electrostatic 
interaction towards the metal due to their negative charges and positioning at the outer 
ends of the side chains, which confers only minor steric hindrance. Comparatively, the 
uncharged acetyl groups and the glucose units play a less significant role in complex 
formation
12
. The addition of small counter ions like Ca
2+ 
will reduce the charge of xanthan 
chain
10
. Thus, at low polymer content the viscosity of XG solutions will decline upon the 
addition of salts, which increases ionic strength
12, 22
. Bergmann et al (2008) observed a 
viscosity decrease in a 0.15% XG solution when ion content was increased
12
. This 
phenomenon occurs because in dilute solutions charge screening with calcium ions 
decreases the polymer’s interaction with water; allowing the XG chains to assume ordered 
helical molecular conformations which occupy a smaller hydrodynamic volume leading to a 
decrease in viscosity
22
. Comparatively, at higher XG concentration, the interaction between 
the polymer molecules increases as salt content increases
3, 10, 22
. This effect outweighs the 
reduction in hydrodynamic volume of the molecules, and hence viscosity increases. It has 
been hypothesized that the increase in viscosity is caused by ion bridging, in which either an 
inter-molecular or intra-molecular crosslink is formed; subsequently increased interaction 
between the polymer chains induces a more rigid network
22
.  A threshold in salt content 
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exists where changes in viscosity of the XG solution is limited, i.e. beyond this point, further 
addition of salts will have little influence on the rheological properties of the gel
3, 14, 23-24
.   
Like Talukdar and Kinget (1995) a 1% gel was chosen for the rheological experiment. The 
viscosity measurements of XG hydrogels containing the respective salts were measured at 
37
o
C
3
.  Figure 3 represents the apparent viscosity of the 1% XG solutions at different shear 
rates. The rheological behaviour of all the samples is characteristic of pseudoplastic or shear 
thinning fluids; that is to say, the apparent viscosity progressively decreases as shear rate 
increases
24
. This observation is in accordance with published data, which explored the 
rheological properties of XG
13, 22-23, 25
. XG solutions exhibit this behaviour because the 
molecules in solution can self-associate and form non-permanent aggregates through 
hydrogen bonding and polymer entanglement
13, 24
. This highly ordered network results in 
high viscosity at low shear rates.  When the shear rate is increased the aggregates are 
disrupted and hence viscosity decreases
13
.   
The power model output values for the consistency index (k), the flow behaviour index (n) 
and the coefficient of determination (R
2
) are listed in Table 4. For a Newtonian fluid the 
power law index is equal to 1; for a shear-thinning fluid it is between 0 and 1; and for a 
shear thickening fluid it is greater than 1
26
. All samples exhibit a good fit to the power law 
equation and as all  values are less than 1, the samples are shear thinning fluids. The 
concentration of hydrogel used in this experiment was 1% which would be considered a 
high XG content; therefore in accordance with previously published works the viscosity of 
the hydrogel should increase as calcium ion content rises
3, 10, 22
. The results in Table 4 are to 
some extent in agreement with these literatures, in that F1 has a higher calcium ion content 
(Chloride salt contributes to 0.340 mmol of Ca
2+ 
per tablet) compared to F2 (Sulfate salt 
contributes to 0.291mmol of Ca
2+ 
per tablet) and exhibits higher viscosity, due to increased 
interactions between XG and calcium ions. The data also illustrates that the presence of salt 
in the XG solution increases viscosity. This is indicated by the lower k value for the 1% XG 
hydrogel in which salt was absent, compared with the hydrogels in which salt was present. 
The results for F3 are unique and are not in accordance with hypothesis that increasing 
calcium concentration increases the viscosity. Dibasic Calcium Phosphate is practically 
insoluble in water (Table 1) because of the strong ionic interaction between the phosphate 
and calcium ions. The formulation F3 (phosphate salt contributed to 0.290mmol of Ca
2+ 
per 
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tablet) has the lowest amount of calcium ions in solution, which are able to interact with the 
XG, yet it has the highest viscosity. Consequently, it can be postulated that another 
mechanism is behind the unique rheological behaviour of this hydrogel. Dario et al. (2010) 
evaluated the effect of Calcium Phosphate on the flow behaviour of 0.4% XG solutions
13
. 
The authors reported that the addition of insoluble calcium salts (CaCO3 and Ca3(PO4)2) 
increased the k values of XG hydrogels; which supports the rheological properties of F3. In 
current study, based on the solubility data of the calcium salt (Table 1), the amount of 
dissociated Ca
2+
 ions from the phosphate salt was in excess quantity relative to the pyruvate 
units of the 1% gel preparation. Hence the presence of solid salt particles in solution may be 
enough to increase the k value. It has also been hypothesized that xanthan chains in the 
solution could bind to the surface of the insoluble calcium particles, building a complex 
network, which increases viscosity
13
.  
 
‘In vitro’ drug release studies 
The release profiles of Sodium p-aminosalicylate from the formulations is displayed in Figure 
4. The data indicates that F2 released the highest fraction of drug followed by F1 and F3. 
Statistical analysis showed difference in terms of the overall fraction released for  the 
samples after 6 hours in contact with the dissolution medium (p <0.05). Post hoc test using 
Games-Howell analysis demonstrated that the overall fraction released for F3 was also 
significantly lower than F2. Drug release from XG matrices begins after the medium comes 
in contact with the tablet and drug at the surface of the unit is dissolved. Figure 4 shows 
that for the first hour of the experiment, the hydrophilicity of the salt governs the release 
rate; with F1 having the highest fraction of released drug followed by F2 and F3. This trend 
suggests that the presence of a more water soluble salt in the formulation will induce a 
faster rate of drug release during the initial phase, through salt dissociation into the 
medium. Furthermore, there is a point where the drug release profiles of F1 and F2 
intercept; at this point the calcium ions within F1 have had sufficient time to interact with 
the XG molecules and strengthen the gel layer. Hence, erosion of the matrix is reduced and 
percentage drug release is lower. Overall, F2 generates the most rapid drug release because 
the formulation has the least viscous gel layer (Table 4) and highest swelling capacity (Figure 
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1), which makes the matrix more susceptible to erosion
3
. Comparatively, F1 has the lowest 
swelling capacity as is highlighted in the swelling studies (Figure 1), thus intuitively F1 should 
have the greatest release rate owing to a shorter diffusion pathway. However, 
experimentally this is not the case because the gel layer is more viscous than that of F2 
resulting in lower drug diffusivity. Conversely, the presence of the hydrophobic phosphate 
salt in F3 produces a formulation with a highly viscous gel layer coupled with modest 
swelling capacity. Accordingly, the core of the tablet remains dry after six hours in contact 
with the medium, which accounts for the lowest overall drug release. Overall, in relation to 
drug release the rheology results show that the apparent viscosity of the gel layer governs 
the erosion rate of the tablet and hence determines drug release kinetics. F2 produces the 
most rapid drug release because it has the least viscous gel layer, which can erode more 
readily. F1 presents a moderate viscosity and therefore intermediate drug release property 
whereas F3 has the lowest rate of drug release underpinned by the most viscous outer gel 
layer as described above.  
The drug release kinetics of the matrices is strongly associated with the structure of the 
polymer network in the gel layer and the arrangement of water molecules within it
10
. In an 
attempt to determine the most suitable mathematical model the in vitro data was analyzed 
using zero order kinetics, first order kinetics, Higuchi, Hixson-Crowell and Korsmeyer Peppas 
kinetic theories. From the kinetic modelling results presented in Table 5, the correlation 
coefficient values indicate that all the formulations show good conformity to the Korsmeyer 
Peppas model, nonetheless F2 and F3 also fit to the first order and Higuchi square root 
kinetic models, respectively. The Higuchi mathematical model is commonly used to describe 
drug release from modified release dosage systems in which drug release is primarily 
diffusional based and matrix swelling and dissolution are negligible
18
. Therefore, the Higuchi 
model is not most appropriate representation of drug release from the XG formulations, 
since drug release from these matrices is considered multifactorial and involves; liquid 
penetration, polymer swelling, drug diffusion and matrix erosion. On the other hand, first 
order kinetic model is partially appropriate as it was described for porous matrix where drug 
release is proportional to the amount of the drug remaining in its interior and was 
independent from swelling and erosion as observed for XG system
18
. 
     
15 
 
The in vitro drug release data was analyzed using the simple power law developed by 
Korsmeyer et al. (1983), which best describes the drug release data from the swollen tablet 
matrices
27-28
. Based on the value of the diffusion exponent (, drug transport in cylinder 
geometry is classified as either Fickian drug release ( = 0.45, non-Fickian also known as 
anomalous transport (0.45 <  < 0.89, or case II transport ( = 0.8929. Fickian 
diffusional transport describes molecular diffusion due to a chemical potential gradient. 
Case II transport is a drug release mechanism associated with stresses and state of 
transition in the hydrophilic glossy polymers, which swell in water or physiological fluids. 
Anomalous transport occurs due to a coupling of Fickian diffusion and polymer relaxation
10
. 
The drug release mechanism from the XG matrices was found to be non-Fickian anomalous 
transport for all formulations based the -value obtained from the Korsmeyer-Peppas 
model (Table 5). This signifies that diffusion, polymer erosion and relaxation are the 
predominant mechanisms of drug release; this finding has also been reported in other 
literature sources 
4,9,10-11,30
. According to Baumgartner et al, (2008) the higher the ionic 
strength the more pronounced the contribution of Fickian diffusion
10
; thus F1 obtained the 
lowest  value because the formulation had the greatest calcium ion content.   
Scanning electron microscope (SEM) images of the matrix tablets at various time points 
were taken in order to visually explain the drug release properties of the three formulations. 
The micrographs of the dry matrix tablets indicates F1 has large airspaces between the 
particles indicating increased porosity visually, whereas F2 and F3 appear to have a more 
densely packed arrangement of particles (Figure 5). Interestingly, after four hours in contact 
with the medium the internal spaces of the three tablets have very different structural 
arrangements. This is partly attributed to the polymer relaxation and formation of gel layer 
upon absorption of dissolution medium
31
.  F1 appears more ‘spindly’ which is likely due to 
the interaction between the XG polymer chains and calcium ions. Comparatively, F2 has a 
more hollow appearance owing to the formulation elevated degree in swelling; 
consequently at the four hours’ time interval the highest fraction of released drug was 
observed. Whereas F3, had the lowest drug release, which was supported by the SEM image 
in which the tablet core appeared intact.  Additionally, the images of the diffusion layer 
highlight the degree of erosion the tablets endured. Remarkably, the diffusion layer of F3 
appears structurally sound and visually highlights the hydrophobicity of the preparation, as 
16 
 
well as the effectiveness of the gel layer as a barrier to water penetration and drug molecule 
diffusion. Presence of bulking agent such as lactose In XG tablets as well as addition of 
soluble calcium ions to the dissolution medium for sodium alginate/XG blend tablets have 
shown to alter the drug release profiles of propranolol HCl 
31,32
. This is owned to the 
hydrophilic property of lactose, and to influence of calcium ions on the gel integrity, 
respectively. From the SEM, adding calcium salts of different solubility profiles is also 
responsible for the difference in appearances of the tablets upon immersion in the 
dissolution medium.     
 
Conclusions 
Overall, the experiments have shown that incorporating CaCl2.2H2O, CaSO4.2H2O or 
CaHPO4.2H2O into XG matrix tablets can modify the drug release behaviour of the 
formulation. It was hypothesized that the more hydrophilic and higher calcium salt content, 
the quicker the expected drug release. This is because the salt can readily dissociate into 
Ca
2+ 
ions that can then interact with XG at a molecular level, and subsequently shorten the 
length of the diffusion pathway. Nonetheless, the sulfate salt had the fastest overall rate of 
drug release and the phosphate salt had the lowest. This phenomenon has been attributed 
partly to the viscosity and structure of the gel layer; with CaSO4.2H2O having the least 
viscous layer followed by CaCl2.2H2O and CaHPO4.2H2O while strong surface structure was 
observed in those tablets containing CaHPO4.2H2O.  It can be pre-assumed that the water 
solubility of the calcium salt plays a role in governing drug release from XG matrices; since 
this physical property determines the properties of the gel layer. Previous works have 
incorporated other matrix controlling agents such as chitosan, alginate to modify drug 
release profiles in addition to xanthan gum. This study shows that by adding readily 
available inorganic calcium salts, matrix properties can be manipulated. In summary, it can 
be concluded that the type of calcium compounds incorporates into XG matrices will impact 
the drug release properties of the formulation.   
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List of table 
Table 1 Properties of inorganic calcium salts 
Calcium salt Molecular 
mass
 
Water solubility 
(gL
-1
) 
CaCl2.2H2O 147.00
* 
950
* 
CaSO4.2H2O 172.17
* 
2.1
* 
CaHPO4.2H2O 172.09
* 
0.3
** 
 
*
Data taken from the handbook of pharmaceutical excipients 6
th
 edition 
33-35
 
** 
Data taken from Allwood and Kearney (1998) 
36
  
 
Table 2 Composition of tablet formulations 
Ingredient/ID Tablet composition (mg) 
F 1 F 2 F3 
Xanthan gum 250 250 250 
Sodium p-aminosalicylate 50 50 50 
Calcium Chloride dihydrate  50 - - 
Calcium Sulfate dihydrate  - 50 - 
Dibasic Calcium Phosphate 
dehydrate 
- - 50 
Avicel PH101 30 30 30 
Magnesium stearate 4.5 4.5 4.5 
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Table 3 Physical properties of tablets. Data expressed as Mean ± SD. 
 
Tablet Property 
Formulation ID 
F1 F2 F3 
 Mass (mg) 390 ± 0.005 386 ± 0.011 390 ± 0.002 
 Drug content (mg) 50.752 ± 0.576 50.952 ± 0.193 50.910 ± 0.244 
Tensile strength (MPa) 0.539 ± 0.029 0.768 ± 0.026 0.876 ± 0.035 
Porosity (%) 33.47 ± 1.09 34.85 ± 1.18 34.96 ± 0.27 
 
 
Table 4 Rheological parameters determined using the power law equation for XG solutions 
prepared using different salts (based on downward curve)  
 
Equation 
component 
Formulation ID 
F1 F2 F3 Control (salt 
absent ) 
K 12.008 11.757 13.869 10.515 
 0.163 0.158 0.140 0.150 
R
2 
0.9998 0.9998 0.9996 0.9999 
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Table 5 Parameters derived from kinetic models for drug release from XG matrices  
Kinetic model/ID Correlation Coefficient (R) and rate of release (k) 
F1  F2  F3  
Zero order 0.9785; 0.090 hr
-1
 0.9721; 0.108 hr-1 0.9852; 0.088 hr
-1
 
First order* 0.9970; -0.18 hr
-1 
0.9978; -0.25 hr
-1
 0.9986; -0.17 hr
-1
 
Higuchi  0.9980; 0.29 hr
-1/2
  0.9955; 0.35 hr
-1/2
 0.9996; 0.28 hr
-1/2
 
Hixson-Crowell** 0.9926, -0.048 hr
-1
 0.9930, -0.062 hr
-1
 0.9960, -0.044 hr
-1
 
Korsmeyer Peppas*** 
n*** 
k*** 
0.9998  
0.51  
0.30 hr
-n
 
0.9977                  
0.62 
0.31 hr
-n
 
0.9995  
0.53 
0.27 hr
-n 
* based on ln unreleased fraction vs. time 
**based on (unreleased fraction)
1/3
 vs. time  
*** where n = diffusion exponent and k = rate constant  
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List of figures  
 
Figure 1 Influence of calcium salts on the swelling profiles of XG matrix tablets in distilled 
water 
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Figure 2 Influence of calcium salts on the erosion profiles of xanthan gum matrix tablets in 
distilled water 
 
Figure 3 The apparent viscosity of 1% XG hydrogels as a function of shear rate at 37
o
C 
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Figure 4 Drug release profiles of Sodium p-aminosalicylate from the XG matrices  
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Figure 5 Micrographs of the dry matrices and the swollen then dried matrices removed at 
four hours   
 
